BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18057318)

  • 1. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV; Link J; Byrnes JK; Dyment DA; Giovannoni G; Hintzen RQ; Sundqvist E; Kockum I; Smestad C; Lie BA; Harbo HF; Padyukov L; Alfredsson L; Olsson T; Sadovnick AD; Hillert J; Ebers GC
    Neurology; 2009 Dec; 73(24):2107-11. PubMed ID: 20018638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
    J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: HLA-DRB1 and multiple sclerosis in Malta.
    Ramagopalan SV; Dyment DA; Sadovnick AD; Ebers GC
    Neurology; 2008 Oct; 71(17):1379. PubMed ID: 18936434
    [No Abstract]   [Full Text] [Related]  

  • 15. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
    J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.